Sinergi Inti Andalan Prima Tbk. vs Phapros Tbk. — how do they compare? Sinergi Inti Andalan Prima Tbk. trades at Rp224 (market cap 4.79T, 416.84M 24h volume), while Phapros Tbk. trades at Rp258 (market cap 215.04B, 158.1K 24h volume). The key difference: Sinergi Inti Andalan Prima Tbk. is far larger — about 22.3× Phapros Tbk.'s market cap, and Sinergi Inti Andalan Prima Tbk. is more actively traded (416.84M versus 158.1K). Which is the better fit depends on your goals.
| INET | PEHA | |
|---|---|---|
Market Cap | 4.79T | 215.04B |
Volume | 416.84M | 158.1K |
Lot | 4.17M | 1.58K |
Turnover | 93.24B | 40.83M |
Average Price | 223.69 | 258.26 |
Value | 93.24B | 40.83M |
Indicative Equilibrium Price | 224 | 258 |
Indicative Equilibrium Volume | 89.2K | 10 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.
Read more on INET →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →